• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of the health and economic consequences of smoking interactive model.吸烟交互模型的健康和经济后果研究进展
Tob Control. 2001 Mar;10(1):55-61. doi: 10.1136/tc.10.1.55.
2
Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.格拉斯哥药房及团体行为支持戒烟服务的成本效益
Addiction. 2009 Feb;104(2):317-25. doi: 10.1111/j.1360-0443.2008.02449.x.
3
[Efficacy and cost-effectiveness of smoking cessation courses in the statutory health insurance: a review].法定医疗保险中戒烟课程的疗效及成本效益:一项综述
Gesundheitswesen. 2009 Nov;71(11):732-8. doi: 10.1055/s-0029-1214400. Epub 2009 Jun 2.
4
Individual cigarette consumption and addiction: a flexible limited dependent variable approach.个人香烟消费与成瘾:一种灵活的受限因变量方法。
Health Econ. 1996 Mar-Apr;5(2):105-17. doi: 10.1002/(SICI)1099-1050(199603)5:2<105::AID-HEC188>3.0.CO;2-I.
5
The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.吸烟史框架:说明戒烟尝试、戒烟方法和新烟民对吸烟流行率、挽救的预期寿命、节省的医疗费用、规划成本、成本效益和投资回报的影响。
Am J Health Promot. 2011 Sep-Oct;26(1):e11-23. doi: 10.4278/ajhp.101014-QUAN-337.
6
Financial Incentives Promote Smoking Cessation Directly, Not by Increasing Use of Cessation Aids.经济激励直接促进戒烟,而非通过增加戒烟辅助工具的使用。
Ann Am Thorac Soc. 2019 Feb;16(2):280-282. doi: 10.1513/AnnalsATS.201808-574RL.
7
Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.健康促进项目的成本效益分析:以荷兰学生预防和戒烟为例的研究
Health Educ Res. 2008 Apr;23(2):310-8. doi: 10.1093/her/cym024. Epub 2007 Aug 4.
8
Cost effectiveness of a mass media-led anti-smoking campaign in Scotland.苏格兰一场由大众媒体主导的反吸烟运动的成本效益。
Tob Control. 1997 Summer;6(2):104-10. doi: 10.1136/tc.6.2.104.
9
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.希腊伐伦克林与安非他酮、尼古丁替代疗法和非药物戒烟的成本效益比较。
Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.
10
[The effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costs].[在西班牙实施戒烟干预措施对发病率、死亡率和医疗保健成本的影响]
Gac Sanit. 2002 Jul-Aug;16(4):308-17. doi: 10.1016/s0213-9111(02)71929-8.

引用本文的文献

1
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.英国戒烟干预措施的成本效益分析:考虑主要神经精神不良事件。
Value Health. 2021 Jun;24(6):780-788. doi: 10.1016/j.jval.2020.12.012. Epub 2021 Mar 11.
2
Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.估算近期推出的改良风险烟草产品对人群健康的影响:不同方法的比较。
Nicotine Tob Res. 2021 Feb 16;23(3):426-437. doi: 10.1093/ntr/ntaa102.
3
Economic evaluation of smoking cessation in Ontario's regional cancer programs.安大略省地区癌症项目中戒烟的经济评估。
Cancer Med. 2018 Sep;7(9):4765-4772. doi: 10.1002/cam4.1495. Epub 2018 Jul 17.
4
Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.二甲双胍联合二肽基肽酶-4抑制剂与二甲双胍联合磺脲类药物治疗2型糖尿病的成本效益分析
BMC Health Serv Res. 2018 Feb 1;18(1):78. doi: 10.1186/s12913-018-2860-0.
5
Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women.韩国成年女性在家中接触二手烟所致终身成本及健康后果的建模分析
BMJ Open. 2017 May 17;7(5):e013292. doi: 10.1136/bmjopen-2016-013292.
6
[Cost-benefit of medical advice for quitting smoking in the Region of Murcia].[穆尔西亚地区戒烟医学建议的成本效益]
Aten Primaria. 2017 Aug-Sep;49(7):407-416. doi: 10.1016/j.aprim.2016.11.006. Epub 2017 Feb 4.
7
Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation.伐尼克兰初始戒烟治疗失败或复发后再治疗的成本效益
Prev Med Rep. 2015 Mar 14;2:189-95. doi: 10.1016/j.pmedr.2015.03.004. eCollection 2015.
8
Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models.戒烟疗法的经济评价:模拟模型的批判性和系统性回顾。
Pharmacoeconomics. 2012 Jul 1;30(7):551-64. doi: 10.2165/11590120-000000000-00000.
9
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.伐仑克林:作为戒烟辅助药物的药物经济学评价。
Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000.
10
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.在比利时,与安非他酮、尼古丁替代疗法、简短咨询和无辅助戒烟相比,伐尼克兰的成本效益:一项BENESCO马尔可夫成本效益分析。
Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

本文引用的文献

1
Health and economic outcomes modeling practices: a suggested framework.健康与经济结果建模实践:一个建议框架。
Value Health. 1998 Jul-Aug;1(2):131-47. doi: 10.1046/j.1524-4733.1998.120131.x.
2
Mortality attributable to tobacco use in Canada and its regions, 1994 and 1996.
Chronic Dis Can. 1999;20(3):111-7.
3
An introduction to Markov modelling for economic evaluation.经济评估中的马尔可夫模型介绍。
Pharmacoeconomics. 1998 Apr;13(4):397-409. doi: 10.2165/00019053-199813040-00003.
4
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.一项关于缓释安非他酮、尼古丁贴片或两者联合用于戒烟的对照试验。
N Engl J Med. 1999 Mar 4;340(9):685-91. doi: 10.1056/NEJM199903043400903.
5
Smoking cessation: evidence based recommendations for the healthcare system.戒烟:针对医疗保健系统的循证建议
BMJ. 1999 Jan 16;318(7177):182-5. doi: 10.1136/bmj.318.7177.182.
6
Tobacco--the growing epidemic.烟草——日益蔓延的流行病。
Nat Med. 1999 Jan;5(1):15-7. doi: 10.1038/4691.
7
State estimates of total medical expenditures attributable to cigarette smoking, 1993.1993年因吸烟导致的医疗总支出的各州估计数。
Public Health Rep. 1998 Sep-Oct;113(5):447-58.
8
State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993.1993财政年度因吸烟导致的医疗补助支出的州估计数。
Public Health Rep. 1998 Mar-Apr;113(2):140-51.
9
Smoking estimate correction.吸烟估计校正。
Public Health Rep. 1998 May-Jun;113(3):191-2.
10
The health care costs of smoking.吸烟的医疗保健成本。
N Engl J Med. 1998 Feb 12;338(7):471-2.

吸烟交互模型的健康和经济后果研究进展

Development of the health and economic consequences of smoking interactive model.

作者信息

Orme M E, Hogue S L, Kennedy L M, Paine A C, Godfrey C

机构信息

The Lewin Group, Bracknell, Berkshire, UK.

出版信息

Tob Control. 2001 Mar;10(1):55-61. doi: 10.1136/tc.10.1.55.

DOI:10.1136/tc.10.1.55
PMID:11226362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1763982/
Abstract

OBJECTIVE

To describe the health and economic consequences of smoking model, a user friendly, web based tool, designed to estimate the health and economic outcomes associated with smoking and the benefits of smoking cessation.

RESULTS

An overview of the development of the model equations and user interface is given, and data from the UK are presented as an example of the model outputs. These results show that a typical smoking cessation strategy costs approximately 1200 pounds sterling per life year saved and 22,000 pounds sterling per death averted.

CONCLUSIONS

The model successfully captures the complexity required to model smoking behaviour and associated mortality, morbidity, and health care costs. Furthermore, the interface provides the results in a simple and flexible way so as to be useful to a variety of audiences and to simulate a variety of smoking cessation methods.

摘要

目的

描述吸烟模型的健康和经济后果,这是一个用户友好的基于网络的工具,旨在估计与吸烟相关的健康和经济结果以及戒烟的益处。

结果

给出了模型方程和用户界面的开发概述,并展示了来自英国的数据作为模型输出的示例。这些结果表明,典型的戒烟策略每挽救一个生命年大约花费1200英镑,每避免一例死亡花费22000英镑。

结论

该模型成功捕捉了模拟吸烟行为及相关死亡率、发病率和医疗保健成本所需的复杂性。此外,该界面以简单灵活的方式提供结果,以便对各种受众有用,并模拟各种戒烟方法。